CN Stock MarketDetailed Quotes
600422 KPC Pharmaceuticals, Inc.
Watchlist
21.18
+0.02+0.09%
Not Open 12/06 15:00 CST
21.41High20.76Low55.37KlotVolume
21.21Open21.16Pre Close116.92MTurnover0.73%Turnover Ratio40.50P/E (TTM)16.05BMarket Cap25.9352wk High41.86P/E (Static)757.99MShares13.1852wk Low3.06P/B16.03BFloat Cap25.93Historical High23.28Limit Up756.98MShs Float-0.40Historical Low19.04Limit Down3.07%Amplitude25.14KlotAsk0.16Dividend TTM21.12Avg Price28.48KlotBid0.76%Div YieldTTM100Lot Size
KPC Pharmaceuticals, Inc. Key Stats
All
YOY

(Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | (Q3)2022/03/31 | (FY)2021/12/31 | (Q9)2021/09/30 | (Q6)2021/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -10.51%1.13B | 23.17%1.24B | 20.55%1.28B | 5.34%1.66B | 40.00%1.26B | -7.73%1.01B | 6.93%1.06B | 6.86%1.57B | -4.00%898.07M | 12.19%1.09B |
Transactional financial assets | 118.82%481.4M | -76.47%80M | ---- | 99.00%319.4M | -53.34%220M | -16.35%340M | -17.29%388M | -52.05%160.5M | -26.74%471.46M | -30.59%406.46M |
Notes receivable and accounts receivable | 5.18%2.89B | 1.62%2.79B | 19.53%2.99B | 28.23%2.58B | 41.04%2.75B | 45.82%2.75B | 47.43%2.5B | 29.62%2.01B | 14.54%1.95B | 24.42%1.88B |
-Notes receivable | -42.22%81.34M | 23.89%111.05M | 87.91%133.47M | -2.45%141.61M | 29.64%140.78M | -19.35%89.63M | -25.27%71.03M | -9.48%145.16M | -22.36%108.59M | -28.57%111.14M |
-Accounts receivable | 7.74%2.81B | 0.87%2.68B | 17.53%2.86B | 30.61%2.44B | 41.71%2.61B | 49.91%2.66B | 51.74%2.43B | 34.13%1.87B | 17.84%1.84B | 30.49%1.77B |
Other receivables (including interest and dividends) | -43.82%124.82M | 3.33%139.43M | 4.08%162.2M | 7.49%147.61M | 23.00%222.17M | -22.59%134.93M | -14.89%155.84M | -11.61%137.33M | 3.09%180.63M | -8.20%174.32M |
-Other receivable | ---- | 3.33%139.43M | ---- | ---- | ---- | -22.59%134.93M | ---- | -11.61%137.33M | ---- | -8.20%174.32M |
Advance payment | 28.49%176.31M | 5.13%159.41M | -14.30%199.75M | -36.05%244.16M | -35.27%137.22M | -42.90%151.63M | 2.55%233.09M | 111.66%381.82M | 0.39%211.99M | 87.36%265.57M |
Inventories | -6.29%1.67B | -2.25%1.79B | -11.99%1.72B | -10.77%1.68B | -4.38%1.78B | 2.09%1.83B | 6.81%1.95B | 9.67%1.88B | 14.91%1.87B | 13.28%1.8B |
Receivable financing | --141.06M | 189.60%176.33M | --178.81M | --46.09M | ---- | --60.89M | ---- | ---- | ---- | ---- |
Assets held for sale | ---- | ---- | ---- | --45.66M | ---- | ---- | ---- | ---- | ---- | ---- |
Other current assets | 178.47%87.46M | -7.31%29.55M | 62.04%39.21M | 43.83%45.88M | -41.72%31.41M | -40.18%31.88M | -75.10%24.19M | -67.39%31.9M | -16.71%53.89M | -1.61%53.3M |
Adjustment items of current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- |
Total current assets | 4.66%6.7B | 1.61%6.41B | 3.99%6.57B | 9.48%6.77B | 13.67%6.4B | 11.22%6.31B | 14.98%6.32B | 11.15%6.18B | 5.14%5.63B | 12.43%5.67B |
Non Current assets | ||||||||||
Other equity investment | 0.00%77.45M | 0.00%77.45M | -28.21%77.45M | -11.88%77.45M | -68.58%77.45M | -68.58%77.45M | -54.74%107.89M | -57.82%87.89M | 30.83%246.47M | 33.73%246.47M |
Other non-current financial assets | -6.73%229.23M | -15.80%209.05M | 34.46%213.22M | 38.22%219.19M | --245.75M | --248.28M | --158.58M | --158.58M | ---- | ---- |
Investment real estate | 32.83%22.79M | 18.04%23M | 739.90%17.07M | 1,180.76%25.09M | 744.02%17.16M | 843.20%19.49M | -3.16%2.03M | -8.13%1.96M | --2.03M | --2.07M |
Long-term equity investment | -11.00%23.56M | -21.83%23.83M | -24.62%23.93M | -24.52%23.98M | -19.61%26.47M | -7.95%30.48M | -4.21%31.74M | -4.21%31.76M | -62.12%32.93M | -62.01%33.12M |
Fixed assets | ---- | -3.51%1.16B | ---- | ---- | ---- | -2.35%1.2B | ---- | -1.24%1.24B | ---- | 12.52%1.23B |
Constru in process | ---- | 13.02%75.83M | ---- | ---- | ---- | -37.60%67.09M | ---- | -42.52%43.51M | ---- | -57.02%107.52M |
Intangible assets | -16.99%320.02M | -14.96%333.49M | -13.85%344.3M | -12.94%355.98M | 0.33%385.52M | 1.30%392.14M | 9.31%399.67M | 10.79%408.88M | 2.98%384.25M | 0.92%387.12M |
Development expenditure | 18.34%211.95M | 11.69%192.86M | -7.87%182.97M | -12.94%174.01M | -20.99%179.1M | -19.49%172.68M | -6.32%198.59M | -0.91%199.88M | -4.21%226.68M | -5.24%214.49M |
Goodwill | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M | 0.00%91.73M |
Long deferred expense | -57.71%20.34M | -56.10%22.86M | -66.46%24.14M | -66.42%25.06M | 27.09%48.1M | 39.54%52.07M | 97.83%71.98M | 61.67%74.61M | -28.75%37.85M | -24.14%37.31M |
Deferred tax assets | 27.85%273.98M | 23.28%272.05M | 20.66%258.55M | 5.03%245.6M | -8.02%214.3M | -6.60%220.68M | -1.29%214.29M | -1.23%233.83M | 14.44%232.98M | 11.13%236.28M |
Usufruct assets | -42.76%40.71M | -49.17%41.36M | -46.71%53.37M | -26.27%58.87M | 58.93%71.12M | 67.80%81.37M | 91.26%100.15M | -19.98%79.84M | --44.75M | --48.49M |
Other non current assets | -26.07%62.1M | 37.43%98.79M | 98.40%140.45M | 115.94%136.08M | 52.23%84M | 118.99%71.88M | 105.68%70.79M | 80.08%63.02M | 40.67%55.18M | -27.25%32.82M |
Adjustment items of non current assets | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- |
Total non current assets | -3.68%2.59B | -3.86%2.62B | -1.57%2.67B | -1.74%2.67B | -0.59%2.69B | 2.22%2.72B | 3.48%2.71B | 2.28%2.71B | 2.83%2.71B | 1.67%2.66B |
Adjustment items of total assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
Total assets | 2.19%9.29B | -0.04%9.03B | 2.32%9.24B | 6.06%9.43B | 9.04%9.09B | 8.34%9.03B | 11.27%9.03B | 8.28%8.89B | 4.38%8.34B | 8.75%8.33B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -20.13%663.73M | -41.18%526.68M | -7.90%636.43M | 42.23%912.76M | 20.84%831.04M | 45.59%895.43M | 21.03%691M | 2.22%641.75M | -3.22%687.7M | -0.99%615.05M |
Notes payable and accounts payable | -3.86%901.95M | -8.44%924.34M | -16.74%1.06B | -21.11%977.12M | 0.97%938.14M | 29.71%1.01B | 58.24%1.28B | 50.36%1.24B | 16.80%929.09M | 26.05%778.29M |
-Notes payable | -29.46%207.23M | -59.45%172.73M | -49.64%355.22M | -53.45%284.02M | 43.91%293.77M | 142.97%425.94M | 372.78%705.36M | 254.09%610.13M | 79.90%204.13M | 25.94%175.31M |
-Accounts payable | 7.81%694.71M | 28.80%751.61M | 23.84%708.07M | 10.30%693.1M | -11.12%644.37M | -3.22%583.57M | -13.09%571.75M | -3.53%628.38M | 6.30%724.96M | 26.08%602.98M |
Contract liabilities | 195.36%87.57M | 123.10%90.89M | 14.57%95.65M | 151.55%186.37M | -12.14%29.65M | -62.46%40.74M | -37.11%83.49M | -9.97%74.09M | -63.67%33.75M | 17.00%108.53M |
Salaries payable | 38.42%167.7M | 64.81%171.21M | 49.27%128.71M | 32.57%144.09M | 68.55%121.15M | 32.94%103.89M | 16.03%86.22M | -8.19%108.69M | 4.39%71.88M | 15.53%78.15M |
Taxs payable | 27.29%247.37M | 2.02%176.18M | 19.27%184.25M | -9.62%169.41M | 24.08%194.33M | 13.65%172.69M | 13.27%154.48M | 30.12%187.44M | 12.59%156.62M | 39.38%151.95M |
Other payable (including interest and dividends) | 2.30%1.32B | 12.34%1.44B | 15.32%1.29B | 9.37%1.3B | 11.44%1.29B | -1.02%1.28B | -2.56%1.12B | -10.04%1.19B | -11.17%1.16B | -8.71%1.29B |
-Dividend payable | ---- | --121.3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | 2.85%1.31B | ---- | ---- | ---- | -1.02%1.28B | ---- | -10.04%1.19B | ---- | -8.67%1.29B |
Hold and for sell liabilities | ---- | ---- | ---- | --22.81M | ---- | ---- | ---- | ---- | ---- | ---- |
Non current liabilities due within one year | -83.54%18.49M | -42.49%65.92M | 250.82%119.7M | 236.56%122.07M | 1,206.95%112.29M | 1,234.78%114.62M | 488.35%34.12M | 60.31%36.27M | 71.84%8.59M | 59.01%8.59M |
Other current liabilities | 164.15%42.74M | 111.90%32.74M | 394.40%55.8M | 389.61%55.98M | 239.11%16.18M | -86.62%15.45M | -34.61%11.29M | 5.68%11.43M | --4.77M | --115.44M |
Adjustment items of current assets | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- |
Total current liabilities | -2.36%3.45B | -5.69%3.42B | 3.39%3.57B | 11.58%3.89B | 15.83%3.53B | 15.35%3.63B | 19.52%3.45B | 10.67%3.49B | -2.09%3.05B | 7.49%3.15B |
Current liabilities | ||||||||||
Long term loan | 104.82%108.55M | -42.00%29M | -59.85%60.1M | -39.70%60M | -46.79%53M | -49.80%50M | 50.15%149.7M | -0.20%99.5M | -0.40%99.6M | -0.20%99.6M |
Long term account payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -52.97%1.05M |
Estimate liabilities | 627.88%34.69M | --34.69M | --34.69M | --35.03M | --4.77M | ---- | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -45.37%11.64M | -41.40%12.87M | 28.37%18.95M | -30.96%10.64M | 31.36%21.31M | 30.05%21.97M | -16.25%14.76M | -16.17%15.42M | -21.85%16.22M | -19.55%16.89M |
Long term deferred income | -8.30%199.86M | -8.67%204.92M | -15.45%206.83M | -15.39%207.58M | -20.59%217.96M | -18.74%224.37M | -10.65%244.64M | -10.32%245.34M | 10.33%274.48M | 13.38%276.1M |
Lease liabilities | -46.59%37.24M | -51.77%36.81M | -20.28%46.6M | -11.30%44.77M | 166.79%69.72M | 189.26%76.33M | 74.79%58.45M | -25.88%50.47M | --26.13M | --26.39M |
Other non current liabilities | -33.85%37.91M | -33.60%38.05M | -32.46%38.27M | -24.91%42.55M | --57.31M | --57.31M | --56.67M | --56.67M | ---- | ---- |
Total non current liabilities | 1.38%429.9M | -17.12%356.35M | -22.66%405.45M | -14.30%400.57M | 1.59%424.06M | 2.37%429.98M | 23.17%524.22M | 1.43%467.4M | 11.23%417.41M | 13.51%420.03M |
Total liabilities | -1.96%3.88B | -6.90%3.78B | -0.05%3.98B | 8.52%4.29B | 14.12%3.96B | 13.82%4.06B | 19.99%3.98B | 9.49%3.95B | -0.66%3.47B | 8.17%3.57B |
Shareholders equity | ||||||||||
Paid-in capital | -0.04%757.99M | -0.02%758.13M | -0.02%758.13M | 0.00%758.26M | 0.00%758.26M | 0.00%758.26M | 0.00%758.26M | 0.00%758.26M | -0.02%758.26M | -0.35%758.26M |
Capital reserve funds | -0.54%1.16B | -0.35%1.16B | -0.93%1.16B | -0.66%1.16B | -0.08%1.16B | -0.01%1.16B | 0.68%1.17B | 0.49%1.17B | -0.36%1.17B | -2.36%1.16B |
Surplus reserve funds | 7.25%355.39M | 7.25%355.39M | 7.25%355.39M | 7.25%355.39M | 13.49%331.38M | 13.49%331.38M | 13.49%331.38M | 13.49%331.38M | 11.11%291.98M | 11.11%291.98M |
Retained profit | 9.21%2.98B | 9.51%2.82B | 6.31%2.85B | 5.95%2.72B | 7.92%2.73B | 6.02%2.57B | 8.67%2.68B | 12.96%2.56B | 15.35%2.53B | 17.48%2.43B |
Less:Treasury stock | -20.76%10.42M | -9.89%11.85M | -54.94%11.85M | -50.00%13.15M | -50.00%13.15M | -50.00%13.15M | 0.00%26.3M | 0.00%26.3M | -28.75%26.3M | -58.20%26.3M |
Other composite income | 242.53%2.73M | 226.39%4.43M | 122.72%3.55M | 127.28%3.81M | 77.23%-1.91M | 55.95%-3.51M | -121.88%-15.62M | -88.60%-13.99M | -647.73%-8.41M | -665.60%-7.96M |
Specific reserves | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M | 0.00%2.48M |
Shareholders equity without minority interests | 5.55%5.25B | 5.69%5.09B | 4.40%5.11B | 4.17%4.98B | 5.48%4.97B | 4.40%4.81B | 5.43%4.9B | 7.47%4.78B | 8.39%4.71B | 9.22%4.61B |
Minority interests | 0.52%162.45M | 1.93%159.39M | -2.51%155.42M | 1.61%159.5M | 3.81%161.61M | -0.41%156.38M | -0.11%159.42M | 3.27%156.98M | 5.55%155.69M | 8.46%157.02M |
Total shareholder equity | 5.40%5.41B | 5.57%5.25B | 4.18%5.27B | 4.09%5.14B | 5.43%5.13B | 4.24%4.97B | 5.25%5.06B | 7.34%4.94B | 8.29%4.87B | 9.20%4.77B |
Total liabilityies and equity | 2.19%9.29B | -0.04%9.03B | 2.32%9.24B | 6.06%9.43B | 9.04%9.09B | 8.34%9.03B | 11.27%9.03B | 8.28%8.89B | 4.38%8.34B | 8.75%8.33B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.